Search Results - "Myositis"

Refine Results
  1. 1
  2. 2

    MYOSITIS ASSOCIATED WITH MALIGNANT TUMORS by O. A. Antelava, A. N. Khelkovskaya-Sergeeva, N. V. Chichasova, S. G. Radenska-Lopovok, S. I. Glukhova

    Published 2016-07-01

    Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired systemic diseases mainly involving skeletal muscles. The main representatives of IIM are polymyositis (PM) and dermatomyositis (DM). Epidemiological surveys demonstrate that there is a relationship between PM/DM and malig...

    Full description

    Subjects: Get full text
    Article
  3. 3

    SIGNIFICANCE OF BLOOD INDICES IN DIFFERENTIAL DIAGNOSTICS OF STREPTOCOCCAL INFECTIONS OF SOFT TISSUES by A. P. Frolov

    Published 2012-07-01

    The retraspective analysis of blood indices of 524 patients with vanous forms of stæptococcal infections of soft tissues was earned out. 282 of them had erysipelas and. cellulitis, 110 had a purulent cellulitis (erysipelas phlegmoneuse), 321 had necrotizing fasciitis and. myositis. It is established...

    Full description

    Subjects: “…necrotizing fasciitis and necrotizing myositis…”
    Get full text
    Article
  4. 4

    Myositis in Scrub Typhus: Atypical Presentation by Parth Sharma, Sahil Attri, Aprajita Garg, Karan Sharma

    Published 2025-07-01

    Scrub infection is caused by Orientia tsutsugamushi, due to the bite of a chigger. It has a wide presentation, including febrile illness, ARDS (acute respiratory distress syndrome), and encephalopathy. However, we report a rare case of myositis in Scrub Typhus.

    Subjects: Get full text
    Article
  5. 5

    Warning from a pediatric patient with severe myositis ossificans combined with femoral fracture: a case report by Mengyao Wang, Jin Cao, Huanye Zhu

    Published 2025-07-01

    Myositis ossificans (MO) is a self-limiting benign ossification disorder, characterized by heterotopic ossification within skeletal muscles. Pediatric MO cases are rarer, easy to be misdiagnosed. The diagnosis of traumatic MO is based on a thorough history, physical examination, and imaging studies....

    Full description

    Subjects: “…myositis ossificans…”
    Get full text
    Article
  6. 6

    Co-occurrence of myositis and neuropathy after anti-CD30 therapy in a late-adolescent Hodgkin lymphoma patient by Adela Della Marina, Lydia Rink, Andreas Hentschel, Michael M. Schündeln, Christopher Nelke, Heike Kölbel, Calvin Tucht, Vera Dobelmann, Tobias Ruck, Tim Hagenacker, Teresinha Evangelista, Ulrike Schara-Schmidt, Andreas Roos

    Published 2025-06-01

    Abstract Objective Immune-related adverse events (irAEs) are recognized in oncology, particularly with immune checkpoint inhibitors and other targeted therapies. Brentuximab Vedotin (BV), is an anti-CD30 antibody–drug conjugate- its association with immune-mediated myositis remains unexplored. We re...

    Full description

    Subjects: “…Myositis…”
    Get full text
    Article
  7. 7

    Musculoskeletal symptoms in juvenile onset systemic lupus erythematosus by M. I. Kaleda, A. N. Arefieva, I. P. Nikishina

    Published 2023-08-01

    In juvenile onset systemic lupus erythematosus (SLE), musculoskeletal involvement is one of the most common manifestations. Musculoskeletal symptoms may be due to disease activity itself, organ damage due to SLE activity, drug exposure, or comorbidities. Although they are not life-threatening, they...

    Full description

    Subjects: Get full text
    Article
  8. 8

    Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis by Judith Cantó-Santos, Laura Valls-Roca, Ester Tobías, Francesc Josep García-García, Mariona Guitart-Mampel, Félix Andújar-Sánchez, Adrià Vilaseca-Capel, Anna Esteve-Codina, Beatriz Martín-Mur, Joan Padrosa, Emma Peruga, Irene Madrigal, Paula Segalés, Carmen García-Ruiz, José Carlos Fernández-Checa, Pedro J. Moreno-Lozano, Albert Selva O’Callaghan, Ana Sevilla, José César Milisenda, Glòria Garrabou

    Published 2025-02-01

    Abstract Inclusion body myositis (IBM) is an inflammatory myopathy that displays proximal and distal muscle weakness. At the histopathological level, the muscles of IBM patients show inflammatory infiltrates, rimmed vacuoles and mitochondrial changes. The etiology of IBM remains unknown, and there i...

    Full description

    Subjects: “…Inclusion body myositis (IBM)…”
    Get full text
    Article
  9. 9

    Pyomyositis as a rare musculoskeletal complication of chickenpox in a pediatric patient case report by Mahmoud Mohamad Sbaihat, Ahmad Khaled Othman, Laith Mohammad AlHseinat, Yousef Mohammad Eid Atoom, Faleh Ahmad Al-Sakarneh, Omar Rasmi Al-Tarawneh, Alia Khlaifat

    Published 2025-10-01

    Chickenpox is a common viral infection that mostly affects children from 5 to 9 years old, but it can also occur at any age group. Although typically self-limiting, chickenpox can rarely cause a severe disease and serious complications in approximately 2% of patients. Musculoskeletal complications,...

    Full description

    Subjects: Get full text
    Article
  10. 10

    Combination of sporadic inclusion body myositis and primary Sjögren’s syndrome: clinical case and review of literature by Yu. I. Khvan, A. N. Khelkovskaya-Sergeeva

    Published 2023-02-01

    The article presents a review of the literature and a clinical observation of a patient with long-term anamnesis of primary Sjögren's syndrome (SS) in combination with sporadic inclusion body myositis (sIBM). The diagnosis of SS was confirmed in accordance with the Russian diagnostic criteria f...

    Full description

    Subjects: “…sporadic inclusion body myositis…”
    Get full text
    Article
  11. 11

    Myositis Ossificans Traumatica of the Temporal Muscle: a Case Report and Literature Review Emphasizing Radiographic Features on Computed Tomography and Magnetic Resonance Imaging by Erika Antonia dos Anjos Ramos, Luciana Munhoz, Basílio Almeida Milani, Fernando Pando de Matos, Emiko Saito Arita

    Published 2019-12-01

    Objectives: Heterotopic bone formation within a muscle is designated as ‘myositis ossificans’, and it is associated with multiple aetiologies, such as trauma, genetic predisposition, post-infection, or undetermined causes. When the disease develops as a result of a trauma, the myositis ossificans is...

    Full description

    Subjects: Get full text
    Article
  12. 12

    Benign Acute Childhood Myositis: Evaluation of Clinical and Laboratory Features by Ecem İpek Altınok, Emine Yurdakul Ertürk, Taner Kasar, Ceren Yapar Gümüş, Volkan Altınok

    Published 2025-04-01

    Objective: Benign acute childhood myositis (BACM) is a self-limiting condition often following viral upper respiratory infections, manifesting with leg pain, difficulty walking, and muscle tenderness. Although the symptoms are distressing, BACM typically resolves without specific treatment, and the...

    Full description

    Subjects: “…benign acute childhood myositis…”
    Get full text
    Article
  13. 13

    Fibrodysplasia Ossificans Progressiva: Literature Review and Case Report by Natalya N. Korableva, Evgeniy V. Berestnev, Sergey M. Kiselyov, Natalya F. Chipsanova

    Published 2023-01-01

    Background. Fibrodysplasia ossificans progressiva (FOP) is a genetic disease of the heterotopic ossification group associated with the mutation in ACVR1/ALK2 gene. FOP is characterized by progressive heterotopic endochondral ossification of connective tissue that occurs in postnatal period. It leads...

    Full description

    Subjects: Get full text
    Article
  14. 14

    Kikuchi-Fujimoto Disease Preceding Overlap Syndrome of Sjögren’s Syndrome and Systemic Lupus Erythematosus: Literature Review Based on a Case Report by Cindy Cindy, Suryo Anggoro Kusumo Wibowo, Anna Ariane, Rudy Hidayat

    Published 2024-07-01

    Kikuchi-Fujimoto disease (KFD) is a benign, self-limiting histiocytic necrotizing lymphadenitis systemic disorder with unknown etiology. KFD has been known for half a century, but difficulties in distinguishing it remain. Its diagnostic significance is related to the increasing prevalence of KFD wi...

    Full description

    Subjects: Get full text
    Article
  15. 15

    Features of systemic autoimmune disease associated with anti-Ku antibodies (descriptions of two clinical cases) by Anna V. Torgashina, Anna N. Khelkovskaya-Sergeeva, Askat O. Abdykerimov, Alsu R. Khalmetova

    Published 2024-09-01

    Anti-Ku antibodies are a special type of myositis-associated antibodies that are characteristic of patients with the overlap syndrome of systemic scleroderma and immune-inflammatory myopathy, as well as occurring in other autoimmune diseases. Patients with these antibodies have their own clinical an...

    Full description

    Subjects: Get full text
    Article
  16. 16

    Overlap of myasthenia gravis, myocarditis, and inflammatory myopathy secondary to immune checkpoint inhibitor (pembrolizumab) on a background of previously undiagnosed thymoma-asso... by O. V. Finleyson

    Published 2025-04-01

    Immune checkpoint inhibitors have been used successfully over the last several years for treatment of many types of advanced cancer. Those agents cause uncontrolled activation of the immune system frequently resulting in immune-related adverse effects and exacerbation of pre-existing autoimmune dise...

    Full description

    Subjects: Get full text
    Article
  17. 17

    Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial by Rebecca Zirnbauer, Simon Hametner, Jutta Bergler‐Klein, Irene Kuehrer, Askin Kulu, Daphni Ammon, Julijan Kabiljo, Anton Stift, Rainer Schmid, Leonhard Müllauer, Clemens Bittermann, Friedrich Laengle, Klaus Machold, Stephan Blüml, Michael Bergmann, Johannes Laengle

    Published 2025-07-01

    ABSTRACT Myositis is a rare (<1%) but potentially severe immune‐related adverse event (irAE) of immune checkpoint inhibitors (ICIs), with a 40%–50% fatality rate. Its incidence and pathology in curative, neoadjuvant settings, particularly with chemoradiotherapy (CRT), remain poorly defined. Given...

    Full description

    Subjects: Get full text
    Article
  18. 18

    Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events? by Jürgen Braun, Kirsten Karberg

    Published 2024-11-01

    Immune checkpoint inhibitors (ICI) such as cytotoxic T-lymphocyte associated protein-4 (CTLA-4), programmed cell death-1 (PD-1), programmed death ligand-1 (PD-L1), and lymphocyte activation gene-3 (LAG-3) are increasingly used to treat cancer patients since they were shown to reduce tumor progressio...

    Full description

    Subjects: Get full text
    Article
  19. 19

    Case Report: Immune checkpoint inhibitor-induced myositis without elevated creatine kinase by Klajdi Begaj, Raphael Wilhelm, Alisa Lepper, Maike Kaufhold, Jakob Veeser, Stephan Grabbe, Henner Stege

    Published 2025-06-01

    Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers like malignant melanoma. However, they can lead to a range of immune-related adverse events (irAEs), impacting various organ systems. Among these, myositis is a rare but serious irAE, typically characterized by...

    Full description

    Subjects: Get full text
    Article
  20. 20

    Muscle strength recovery in patients with idiopathic inflammatory myopathy with different myositis-specific autoantibodies by Naoki Mugii, Yasuhito Hamaguchi, Fujiko Someya, Pleiades Tiharu Inaoka, Sho Horie, Natsumi Fushida, Tasuku Kitano, Ko Fujii, Jiro Nishio, Kyosuke Oishi, Takashi Matsushita

    Published 2025-07-01

    This study aims to assess muscle strength recovery in patients with idiopathic inflammatory myopathy (IIM) with three myositis-specific autoantibodies (MSAs). Forty-eight IIM patients (19 with anti-TIF1-γ Ab, 21 with anti-ARS Ab, and 8 with anti-SRP Ab) were included. Physical exercise began one wee...

    Full description

    Subjects: Get full text
    Article